↓ Skip to main content

PLOS

I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe

Overview of attention for article published in PLOS ONE, November 2011
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
62 Mendeley
Title
I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe
Published in
PLOS ONE, November 2011
DOI 10.1371/journal.pone.0027622
Pubmed ID
Authors

Esther Kissling, Marta Valenciano, Jean Marie Cohen, Beatrix Oroszi, Anne-Sophie Barret, Caterina Rizzo, Pawel Stefanoff, Baltazar Nunes, Daniela Pitigoi, Amparo Larrauri, Isabelle Daviaud, Judit Krisztina Horvath, Joan O'Donnell, Thomas Seyler, Iwona Anna Paradowska-Stankiewicz, Pedro Pechirra, Alina Elena Ivanciuc, Silvia Jiménez-Jorge, Camelia Savulescu, Bruno Christian Ciancio, Alain Moren

Abstract

In the third season of I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe), we undertook a multicentre case-control study based on sentinel practitioner surveillance networks in eight European Union (EU) member states to estimate 2010/11 influenza vaccine effectiveness (VE) against medically-attended influenza-like illness (ILI) laboratory-confirmed as influenza.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 61 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 29%
Student > Ph. D. Student 9 15%
Student > Master 7 11%
Student > Bachelor 5 8%
Other 5 8%
Other 11 18%
Unknown 7 11%
Readers by discipline Count As %
Medicine and Dentistry 27 44%
Agricultural and Biological Sciences 10 16%
Nursing and Health Professions 6 10%
Immunology and Microbiology 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 5 8%
Unknown 10 16%